Trial · NCT04404361
Adverse events66
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 66
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Alanine aminotransferase increased | Hepatobiliary disorders | Pacritinib and SOC | 15 | 96 | 17 |
| other | Alanine aminotransferase increased | Hepatobiliary disorders | Placebo and SOC | 17 | 101 | 19 |
| other | anaemia | Blood and lymphatic system disorders | Pacritinib and SOC | 12 | 96 | 12 |
| other | anaemia | Blood and lymphatic system disorders | Placebo and SOC | 18 | 101 | 18 |
| other | bradycardia | Cardiac disorders | Pacritinib and SOC | 15 | 96 | 15 |
| other | bradycardia | Cardiac disorders | Placebo and SOC | 11 | 101 | 11 |
| other | constipation | Gastrointestinal disorders | Pacritinib and SOC | 12 | 96 | 12 |
| other | constipation | Gastrointestinal disorders | Placebo and SOC | 13 | 101 | 13 |
| other | hypokalaemia | Metabolism and nutrition disorders | Pacritinib and SOC | 12 | 96 | 12 |
| other | hypokalaemia | Metabolism and nutrition disorders | Placebo and SOC | 12 | 101 | 17 |
| other | hyperkalaemia | Metabolism and nutrition disorders | Pacritinib and SOC | 9 | 96 | 9 |
| other | hyperkalaemia | Metabolism and nutrition disorders | Placebo and SOC | 11 | 101 | 17 |
| other | acute kidney injury | Renal and urinary disorders | Pacritinib and SOC | 9 | 96 | 15 |
| other | acute kidney injury | Renal and urinary disorders | Placebo and SOC | 7 | 101 | 7 |
| other | hypotension | Cardiac disorders | Pacritinib and SOC | 8 | 96 | 9 |
| other | hypotension | Cardiac disorders | Placebo and SOC | 8 | 101 | 13 |
| other | diarrhoea | Gastrointestinal disorders | Pacritinib and SOC | 12 | 96 | 12 |
| other | diarrhoea | Gastrointestinal disorders | Placebo and SOC | 4 | 101 | 4 |
| other | Aspartate aminotransferase increased | Hepatobiliary disorders | Pacritinib and SOC | 9 | 96 | 9 |
| other | Aspartate aminotransferase increased | Hepatobiliary disorders | Placebo and SOC | 6 | 101 | 6 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04404361/events